CANNAGISTICS INC. : Change of directors or senior management, financial statements and supporting documents (form 8-K)

Item 5.02 Departure of directors or certain officers; Election of directors; Appointment of certain officers; Compensatory provisions of certain agents.

Effective from November 9, 2021, the following people have been appointed to the incumbent’s board of directors:

Name                      Age Position
Jim Morrison              62  Chairman of the Board of Directors

Dr. Babak “Bobby” Ghalili 56 Director

Jim Morrison was previously Chairman of L’Oréal for 9 years, he acquired Redken
and Matrix and led an average growth of over 20%. As CEO, he led the first celebrity-focused video shopping app in partnership with SPRINT; Graham webb, one of the most successful startups in the field of hair care; and Sexy hair concepts
For four years. He was Chairman and CEO and Director of Regen Biowellness, Inc., (Previously Availa Bio, Inc.), since May 2020, a supplier of health and wellness products.

Dr. Babak “Bobby” Ghalili, DMD, is one of the largest periodontal and reconstructive dentists in the field, he is an associate professor of periodontal surgery at New York University and the New Jersey University of Medicine and Dentistry. Dr Ghalili graduated from Brandeis University, Tufts University, and UMDMJ, and author of 21 patents (6 patents issued and 15 patents pending).

Effective from November 9, 2021, the following person has resigned from his position as director of the incumbent but will remain Vice-President of Operations / Compliance reporting directly to the Board of Directors.

Name Position

James W. Zimbler Vice-president / director

The resigning director has stated in his resignation letter that his resignation as Chairman does not imply or imply in any way that there is a dispute or disagreement regarding the operations, policies or practices of the Company. Mr. Zimbler will remain Vice President of Operations / Compliance and Special Advisor to the Board of Directors.

Each resigning officer has received a copy of their disclosure, at least on the day the incumbent files the disclosure with the Commission. Each officer will have the opportunity to provide the registrant with a letter or response indicating that they agree with the statements made by the registrant in this section 5.02, and if not, indicating the points on which they disagree. OK.

Item 9.01  Financial Statements and Exhibits



(d) Exhibits.



Exhibit No.   Exhibit

                Resignation Letter of James W. Zimbler as Vice-President and
   17.1       Director, dated November 1, 2021




  2

© Edgar online, source Previews